Dianthus Therapeutics says Phase 3 CAPTIVATE trial in CIDP now needs fewer than 200 patients in Part A

Dianthus Therapeutics says its Phase 3 CAPTIVATE trial in CIDP now needs fewer than 200 patients in Part A, with Part A results expected by end-2027 and Part B by end-2028.

Detected & updated continuously · Source: Nebula